Who Paid My Doc
Gam10-10
Research payments
$768,676
Through program year 2022, $768,676 in research payments was reported against Gam10-10, across 52 payments, paid by Octapharma USA, Inc..
- Paid by
- Octapharma USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $16,200 | 5 |
| 2021 | Research | $752,476 | 47 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Richard Casey Covington, LA Named on 10 payments
- Christopher Fiack Honolulu, HI Named on 6 payments
- Norman Specht Loma Linda, CA Named on 5 payments
- Usman Shah Honolulu, HI Named on 4 payments
- Alpesh Amin Orange, CA Named on 4 payments
- Zuhair Ballas Iowa City, IA Named on 3 payments
- Kent Stock Charleston, SC Named on 2 payments
- Casmiar Nwaigwe Minot, ND Named on 2 payments
- John Blamoun Midland, MI Named on 2 payments
- Shadaba Asad Las Vegas, NV Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.